Evidence map›Paper›PMID 29760961›Full record

ArticleEuropean journal of microbiology & immunology2018

CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria.

David Olusoga Ogbolu, O A Terry Alli, Mark Alexander Webber, Adeolu Sunday Oluremi, Omoboriowo Moses Oloyede

Open access · diamondAbstract read
In one paragraph

Article in European journal of microbiology & immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Identification of natural CTXM-15 inhibitors from aqueous extract of endophytic bacteria Cronobactersakazaki.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  12. Extended-Spectrum Beta-Lactamases ProducingInfection and drug resistance · 2022
    Review
  13. Beta-lactamase resistance genes inAfrican journal of laboratory medicine · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

David Olusoga OgboluDepartment of Biomedical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Osogbo Campus, Nigeria.
O A Terry AlliDepartment of Biomedical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Osogbo Campus, Nigeria.
Mark Alexander WebberAntimicrobials Research Group, Immunity and Infection, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Adeolu Sunday OluremiDepartment of Biomedical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Osogbo Campus, Nigeria.
Omoboriowo Moses OloyedeDepartment of Biomedical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Osogbo Campus, Nigeria.
Ladoke Akintola University of Technology · NGUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Lactam antibiotics are widely used to treat urinary tract infections in Nigeria. This study aimed to determine the presence and characteristics of extended spectrum β-lactamases in commonly isolated uropathogenic Gram-negative bacteria (GNB) in Nigeria. Fifty non-duplicate GNB isolates consisting of

Indexed as

antibioticsextended spectrum β-lactamasesNigeriaresistanceuropathogens

Identifiers

PMID29760961
PMCPMC5944422
OpenAlexW2802050411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.